Carolyne Malizia
Aspire Pharma has appointed of Carolyne Malizia as Chief People Officer
Read More
Author: PharmaTimes
Number blocks
How the pharma industry can navigate the data maelstrom
Read More
Gene genies
Ensuring broader access to life-changing gene therapies
Read More
Evolutionary tactic
Can synthetic human embryos really replace research animals?
Read More
Human beginning
Applying AI to your clinical resourcing strategy won’t end humankind
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
